Thanks, Viking. I misunderstood your post and hadn't yet read the follow-ups. Now I realize you were talking about another company like Merck not taking an equity share in NWBO, but instead, partnering on a trial. I see in other posts you talk about upfront payments, etc. I'm in your camp! No need to dilute NWBO's worth to its investors!